Eden Research (LON:EDEN) Trading Down 4.7% – Here’s Why

Eden Research plc (LON:EDEN)’s stock price traded down 4.7% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.43 ($0.04). 291,737 shares changed hands during mid-day trading, a decline of 69% from the average session volume of 928,598 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 4.7 %

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The firm has a market cap of £18.29 million, a PE ratio of -12.02 and a beta of 0.92. The company has a 50-day simple moving average of GBX 3.88 and a 200 day simple moving average of GBX 3.95.

Insider Activity at Eden Research

In related news, insider Lykele van der Broek purchased 256,000 shares of the company’s stock in a transaction that occurred on Thursday, February 6th. The shares were purchased at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,975.16). Also, insider Alexander John Abrey bought 540,540 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was bought at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,396.86). 14.02% of the stock is owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.